Investigational Drug Information for Prinomastat
✉ Email this page to a colleague
What is the drug development status for Prinomastat?
Prinomastat is an investigational drug.
There have been 3 clinical trials for Prinomastat.
The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 1998.
The most common disease conditions in clinical trials are Nervous System Neoplasms, Glioblastoma, and Central Nervous System Neoplasms. The leading clinical trial sponsors are Pfizer and [disabled in preview].
Summary for Prinomastat
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 3,812 |
| WIPO Patent Applications | 1,520 |
| Japanese Patent Applications | 140 |
| Clinical Trial Progress | Phase 3 (1998-03-01) |
| Vendors | 0 |
Recent Clinical Trials for Prinomastat
| Title | Sponsor | Phase |
|---|---|---|
| Prinomastat Plus Temozolomide Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | Pfizer | Phase 2 |
| Prinomastat and Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Non-small Cell Lung Cancer | Pfizer | Phase 3 |
| Chemotherapy in Treating Patients Who Have Metastatic Prostate Cancer | Pfizer | Phase 3 |
Clinical Trial Summary for Prinomastat
Top disease conditions for Prinomastat
Top clinical trial sponsors for Prinomastat
US Patents for Prinomastat
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
